PR
EMN icon

Payden & Rygel’s Eastman Chemical EMN Stock Holding History

Payden & Rygel’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-190
Closed -$15K – 137
2022
Q4 		$15K Hold
190
– – ﹤0.01% 135
2022
Q3 		$14K Sell
190
-1,340
-88% -$120K ﹤0.01% 136
2022
Q2 		$137K Sell
1,530
-178,000
-99% -$18.4M 0.01% 132
2022
Q1 		$20.1M Buy
179,530
+1,100
+0.6% +$129K 1.02% 58
2021
Q4 		$21.6M Buy
+178,430
New +$19.8M 1% 56
2021
Q2 		– Sell
-125,900
Closed -$13.9M – 129
2021
Q1 		$13.9M Buy
+125,900
New +$13.7M 0.64% 70
2014
Q1 		– Sell
-100
Closed -$8K – 224
2013
Q4 		$8K Hold
100
– – ﹤0.01% 196
2013
Q3 		$8K Hold
100
– – ﹤0.01% 178
2013
Q2 		$7K Buy
+100
New +$6.97K ﹤0.01% 184

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Payden & Rygel's EMN Position: Q1 2023 in Review

Payden & Rygel sold out of Eastman Chemical (EMN) in Q1 2023, closing a stake of 190 shares — an estimated $15K sold.

Payden & Rygel first reported a position in EMN in Q2 2013 and held it in 9 quarters. The position peaked at $21.6M in Q4 2021. 694 funds tracked by Wall St. Rank hold EMN as of Q1 2023.

  • Payden & Rygel reported no remaining Eastman Chemical position as of Q1 2023 after selling out during the quarter.
  • Payden & Rygel sold 190 Eastman Chemical shares in Q1 2023, an estimated $15K.
  • Payden & Rygel first reported a position in Eastman Chemical in Q2 2013 and held it in 9 quarters.
  • Payden & Rygel's Eastman Chemical position peaked at $21.6M in Q4 2021.
  • 694 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2023.

Based on Payden & Rygel's 13F filing for Q1 2023, filed 10 May 2023.